| 1 |
35159480 | Meroterpenoid-Rich Ethanoic Extract of Sargassum macrocarpum Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice. | 2022 Jan 25 |
1 |
| 2 |
35359021 | Celecoxib has Preventive and Therapeutic Benefits against Nephrotoxicity Caused by Gentamicin in Mice. | 2022 Jun |
2 |
| 3 |
34372885 | Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice. | 2021 Aug 9 |
1 |
| 4 |
30875493 | Celecoxib aggravates atherogenesis and upregulates leukotrienes in ApoE-/- mice and lipopolysaccharide-stimulated RAW264.7 macrophages. | 2019 May |
2 |
| 5 |
29132705 | IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. | 2018 Apr |
1 |
| 6 |
26856544 | Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension. | 2016 May |
1 |
| 7 |
26954392 | Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line. | 2016 |
1 |
| 8 |
27580523 | Celecoxib attenuates depressive-like behavior associated with immunological liver injury in C57BL/6 mice through TNF-α and NF-κb dependent mechanisms. | 2016 Oct 15 |
1 |
| 9 |
20630498 | IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells. | 2010 Sep |
1 |
| 10 |
20657653 | Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. | 2010 Jul 15 |
1 |
| 11 |
19109188 | Immune complex/Ig negatively regulate TLR4-triggered inflammatory response in macrophages through Fc gamma RIIb-dependent PGE2 production. | 2009 Jan 1 |
1 |
| 12 |
16038627 | Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. | 2005 Aug |
2 |
| 13 |
12928598 | Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice. | 2003 Sep-Oct |
1 |
| 14 |
11853703 | Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro. | 2002 Feb 1 |
3 |